Business Description
Blackrock Health Sciences Trust
NAICS : 523991
SIC : 6733
ISIN : US09250W1071
Share Class Description:
BME: CE with IsEquityFundamentalDataAvailable = 1 in GidDescription
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 1 | |||||
Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 8/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Book Growth Rate | 0.5 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 48.71 | |||||
9-Day RSI | 61.51 | |||||
14-Day RSI | 64.33 | |||||
3-1 Month Momentum % | 2.62 | |||||
6-1 Month Momentum % | -3.89 | |||||
12-1 Month Momentum % | 9.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 7.31 | |||||
Dividend Payout Ratio | 0.53 | |||||
3-Year Dividend Growth Rate | 7.2 | |||||
Forward Dividend Yield % | 7.31 | |||||
5-Year Yield-on-Cost % | 9.2 | |||||
3-Year Average Share Buyback Ratio | 2.3 | |||||
Shareholder Yield % | 9.82 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Net Margin % | 99.27 | |||||
FCF Margin % | 70.4 | |||||
OCF Margin % | 70.4 | |||||
ROE % | 14.23 | |||||
ROA % | 14 | |||||
Years of Profitability over Past 10-Year | 8 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 7.28 | |||||
PE Ratio without NRI | 7.28 | |||||
PS Ratio | 8.37 | |||||
PB Ratio | 0.98 | |||||
Price-to-Tangible-Book | 0.98 | |||||
Price-to-Free-Cash-Flow | 9.67 | |||||
Price-to-Operating-Cash-Flow | 9.67 | |||||
EV-to-Revenue | 7.17 | |||||
EV-to-FCF | 10.18 | |||||
Price-to-Projected-FCF | 0.96 | |||||
Price-to-Graham-Number | 0.56 | |||||
FCF Yield % | 9.82 | |||||
Forward Rate of Return (Yacktman) % | 1.04 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:BME
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Blackrock Health Sciences Trust Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 77.536 | ||
| EPS (TTM) ($) | 5.911 | ||
| Beta | 0.5471 | ||
| 3-Year Sharpe Ratio | -0.1 | ||
| 3-Year Sortino Ratio | -0.13 | ||
| Volatility % | 15.78 | ||
| 14-Day RSI | 64.33 | ||
| 14-Day ATR ($) | 0.645816 | ||
| 20-Day SMA ($) | 41.8555 | ||
| 12-1 Month Momentum % | 9.6 | ||
| 52-Week Range ($) | 35.03 - 44.35 | ||
| Shares Outstanding (Mil) | 12.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Blackrock Health Sciences Trust Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Blackrock Health Sciences Trust Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| USD 0.262100 Cash Dividend | 2026-09-15 | In 64 days | ||
| Second quarter earnings results for 2026 | 2026-09-04 | In 53 days | ||
| USD 0.262100 Cash Dividend | 2026-08-14 | In 32 days | ||
| USD 0.262100 Cash Dividend | 2026-07-15 | In 2 days | ||
| General meeting for 2026 | 2026-07-10 10:00 | 43.47 (-0.09%) | ||
| USD 0.262100 Cash Dividend | 2026-06-15 | 40.94 (-0.02%) | ||
| USD 0.262100 Cash Dividend | 2026-05-15 | 39.63 (+0.13%) | ||
| USD 0.262100 Cash Dividend | 2026-04-15 | 40.05 (+1.50%) | ||
| USD 0.262100 Cash Dividend | 2026-03-13 | 40.23 (-1.03%) | ||
| Annual report for 2025 | 2026-03-05 | 42.20 (+0.00%) |
Show
Entries
Blackrock Health Sciences Trust Frequently Asked Questions
What is Blackrock Health Sciences Trust(BME)'s stock price today?
The current price of BME is $43.01. The 52 week high of BME is $44.35 and 52 week low is $35.03.
When is next earnings date of Blackrock Health Sciences Trust(BME)?
The next earnings date of Blackrock Health Sciences Trust(BME) is 2026-09-04 Est..
Does Blackrock Health Sciences Trust(BME) pay dividends? If so, how much?
The Dividend Yield %  of Blackrock Health Sciences Trust(BME) is 7.31% (As of Today), Highest Dividend Payout Ratio of Blackrock Health Sciences Trust(BME) was 1.78. The lowest was 0.31. And the median was 0.52. The  Forward Dividend Yield % of Blackrock Health Sciences Trust(BME) is 7.31%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:BME
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| BlackRock to Host Healthcare and Megatrend Update Call on May 11, 2023 at 2:00pm ET | 2023-05-10 |
Articles on Blackrock Health Sciences Trust
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers